Publication | Open Access
Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
75
Citations
14
References
2011
Year
Intraperitoneal catumaxomab is a promising option for the treatment of PC from GI cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1